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HydrophobicityAge-related cataract (ARC) is a multifactorial disease and the leading cause of blindness worldwide.
Genetic predisposition in association with other etiological factors may contribute to ARC. However, gene
mutation studies on ARC are scanty. In the present work, we identiﬁed a genetic variation (F71L) in the
exon-2 of CRYAA (αA-crystallin) gene in three unrelated female sporadic cases among 711 ARC patients but
not in 265 normal non-cataractous controls by SSCP and RFLP analysis. By comparing human recombinant
wild-type and F71L-αA-crystallin, we characterized the functional signiﬁcance of this missense mutation.
Chromatography, ﬂuorescence and far- and near-UV CD studies indicated that F71L missense mutation did
not signiﬁcantly affect the apparent molecular mass, secondary and tertiary structures and hydrophobicity
of αA-crystallin. While the mutant αA-crystallin displayed signiﬁcant (35–90%) loss of chaperone-like
activity (CLA) in thermal aggregation of carbonic anhydrase, βL- and γ-crystallins, it showed moderate
(10–50%) loss in CLA in DTT-induced aggregation of insulin and lysozyme. This is the ﬁrst report of an αA-
F71L mutation being associated with ARC and suggests that ARC in individuals carrying this mutation
(F71L) might be due to the overall loss of in vivo chaperone activity due to interaction with other
environmental factors.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Cataract results from loss of transparency of the normal crystalline
eye lens mainly due to the disruption of micro architecture of lens.
Human cataract is a debilitating eye disease that afﬂicts millions
worldwide. Cataract accounts for an estimated 16 million cases of
blindness worldwide, with approximately half of all cases originating
from Africa and Asia [1,2]. Despite the availability of treatment,
cataracts still comprise a signiﬁcant risk for visual impairment all overfonic acid; ARC, age-related
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ll rights reserved.the world, particularly in older individuals. Approximately 80% of
cataracts are age-related, the cause of which is unknown but, gene-
rally age-related cataracts (ARC) are considered as a multifactorial
disease [1,2]. In the developing countries prevalence of cataracts is
higher and onset is earlier, implicating contribution of additional
socio-demographic and medical factors including genetic to the deve-
lopment of ARC.
Although, epidemiological research has been focused mostly on
the role of environmental risk factors in ARC, recent studies provided
the evidence for the contribution of genetic factors in the pathoge-
nesis of ARC [3,4]. The Lens Opacity Case Control Study indicated
that a positive family history was a risk factor for mixed nuclear and
cortical cataracts [5] and the Italian American Cataract Study Group
supported a similar role for family history as a risk factor in cortical,
mixed nuclear and cortical, and posterior subcapsular cataracts [6].
The Framingham Offspring Eye Study showed that individuals with
an affected sibling had three times the likelihood of having a cataract
[7]. Results of the Beaver Dam Eye Study suggested that a single
major gene could account for as much as 35% of nuclear and up to
75% of cortical cataract variability [8]. The twin eye study recognized
importance of genetic component with heritability accounting for
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that hereditary tendency was consistent with a combination of
additive and dominant genes [9]. Similarly, the genetic factors were
found to account for approximately 48% of the risk for nuclear
cataract [10].
A recent study identiﬁed several loci through the genome scan on
age-related cortical cataracts [11]. Although, these loci did not coin-
cide with the map coordinates of known crystallin genes, the study
revealed the weaker loci are critical for age-related cortical cataract or
act as modiﬁers, and suggested that the pathways and genes that are
less crucial to the development of the lens ﬁbers may play a role in
ARC. Over the past few years, attempts are being made for the
identiﬁcation of new loci for ARC. Identifying the genes and cha-
racterizing the proteins they encode will provide better comprehen-
sion of the molecular processes that are involved in the cataract
development.
Although, evidence for the genetic component to the develop-
ment of ARC is increasing, mutation(s) in gene(s) that are associated
with ARC are very few compared to those for congenital and
hereditary cataracts. α-Crystallin, a member of the small heat shock
protein family constitutes a major portion of the eye lens cytoplasm
[12]. Eye lens α-crystallin is composed of two subunits, αA and αB,
encoded by CRYAA and CRYAB genes respectively. In humans, the
CRYAA gene is found on chromosome 21 and codes for a 173-residue
protein, while the CRYAB gene is found on chromosome 11, coding for
a 175-residue protein [13]. It is now recognized that α-crystallin
functions like a chaperone and plays a decisive role in the
maintenance of eye lens transparency (reviewed in [13,14]).
Conversely, it is well established that certain point mutations in αA
and αB-crystallin genes are linked with non-syndromic, hereditary
human cataracts (reviewed in [13,14]). In αA-crystallin, R49C and
W9X mutations in the N-terminal domain, and the R116C, R116H, and
G98R in the C-terminal domain are known to cause human cataracts.
In αB-crystallin, the C-terminal R120G, 450delA, D140N mutations,
and the N-terminal P20S mutation cause human cataracts. Many of
these mutations are inherited by autosomal dominant mechanisms
expressing congenitally or early in life. We have investigated the
genetic variations in the three exons of CRYAA gene among patients
with different types of ARC and report the mutations detected in
exon-2 of CRYAA, which was further analyzed for its functional role in
causing opacity of the lens.
2. Subjects, materials and methods
2.1. Patients
We conducted a case–control study of different types of ARC
during the period of “2003–2009”. The Ethics Committee of Depart-
ment of Genetics, Osmania University, approved this study. About 711
cases with different types of ARC were screened for mutations in the
exon-2 of CRYAA gene. The patients studied were referred to Sarojini
Devi Eye Hospital (SDEH) and Institute of Ophthalmology, Hyderabad,
India. Diagnosis of different types of cataracts was done based on the
silt-lamp examination by an ophthalmologist following LOC-III
Classiﬁcation.
2.2. Inclusion and exclusion criteria
Only primary cases of cataracts were included in the present study.
Patients with secondary cataracts like acquired cataracts that are
caused due to trauma, toxins, etc., and the complicated cataracts that
occur due to inﬂammatory and degenerative ocular diseases have
been excluded from the study. In addition, patients with associated
conditions like diabetes, hypertension, myopia, glaucoma, any
syndrome and those who were under medication like steroids etc.,
were also not considered.2.3. Controls
A total of 265 randomly selected age and sex matched normal
healthy individuals without the history of cataract, diabetes, hyper-
tension, and other ocular diseases were used as controls to compare
with patients group.
2.4. Collection of data and blood samples
From all the patients and controls included in the study,
informationwas collected using a speciﬁed proforma. The information
recorded included—sex, age, age at onset, duration of disease, type of
cataract, occupation, body mass index (BMI), menarcheal and
menopausal history for female patients, any other associated condi-
tions, information on habits, diet and detailed four generation family
history. The information collected was cross-matched with the
accompanying relatives who were mostly ﬁrst-degree relatives. Five
to 10 ml of venous blood was collected in EDTA vaccutainers from ARC
patients and control subjects. The samples were collected with
informed consent of the subjects after explaining to them the purpose
of the study. Samples were collected only from those who voluntarily
co-operated to participate in the study.
2.5. DNA isolation
DNA was isolated from blood using salting out method [15].
2.6. SSCP analysis
Mutation screening was carried out using single strand conforma-
tion polymorphism (SSCP) analysis. PCR ampliﬁcation (Applied
Biosystems-9800 Fast Thermal Cycler) was performed with 50 ng of
genomic DNA, in 100 μl PCR reactionmixture containing 10 μl 10× PCR
buffer 200 μM each dATP, dGTP, dTTP, dCTP; 5.0 pmol of each primer
and 2.5 U taq polymerase. The primers used were forward primer—
5′-CTGTCTCTGCCAACCCCAGCAG-3′ and reverseprimer—5′-CCCTGTCCC-
ACCTCTCAGTGCC-3′. The PCR conditions were, initial denaturation at
95 °C for 2min, denaturation at 94 °C for 45 s, annealing at 65 °C for 45 s,
and extension at 72 °C for 45 s, for 30 cycles followed byﬁnal extension at
72 °C for 5min. The PCR products (223 bp) were run on 0.8% agarose gel
using ethidium bromide stain andmonitored under UV transilluminator.
The PCR products were denatured and snap cooled immediately. The
denatured PCR products were analyzed by non-denaturing 12%
polyacrylamide gel electrophoresis at 100 V for 16–18 h at constant
temperature using an Amersham (Pharmacia Biotech SE600-15-1.5)
electrophoresis unit. Silver stainingwasdone tovisualize thebands.With
the detection of a mobility shift, the exact nature of mutation was
conﬁrmed by sequencing on an automated DNA sequencer (Applied
Biosystems).
2.7. Restriction fragment length polymorphism (RFLP) analysis
For RFLP analysis the primers were speciﬁcally designed by
introducing 2 mismatches within the forward primer (forward
primer—5′-AGGTTCAATCCGACCGGGACAAGAT-3′ and reverse primer—
5′-CCCTGTCCCACCTCTCAGTGCC-3′) which generated two recognition
sites for Dpn II restriction enzyme one at 22 bp and another at 75 bp of
ampliﬁed products. The digested products produce three fragments of
75, 60 and 22 bp for wild-type and only two fragments of 97 and 60 bp
for mutant due to loss of site at 22 bp. PCR ampliﬁcationwas performed
with 50 ng of genomic DNA in 100 μl PCR reaction mixture containing
10 μl 10× PCR buffer (100 mM Tris–HCl, pH 8.8, 500 mM KCl, 15 mM
MgCl2, 0.01%w/vgelatin), 200 μMeachdATP, dGTP, dTTP, dCTP, 5.0 pmol
of each primer and 2.5 U taq polymerase. The PCR conditions were:
initial denaturation 95 °C for 2 min, denaturation at 94 °C for 1 min,
annealing at 60 °C for 1 min, and extension at 72 °C for 1 min, for
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products (157 bp) were checked for ampliﬁcation on 0.8% agarose gel
using ethidium bromide stain under UV transilluminator. The PCR
products were restriction digestedwith 2 U of Dpn II restriction enzyme
(5′↓GATC restriction site) (New England Biolabs) at 37 °C for 12 h. The
restriction fragments were separated on 15% acrylamide gels by elec-
trophoresis for 3 h at 150 V. The staining of the PAGE gels was done
using ethidium bromide and the bands were visualized under UV
transilluminator.
2.8. Cloning and expression of wild-type and mutant αA-crystallin
Human αA-crystallin cDNA was cloned into pET-23d (+) vector
(Novagen, Gibbstown, NJ) [16,17]. This cloned cDNA was used as a
template to generate the F71L mutation in the αA-crystallin gene
using a quick-change site directed mutagenesis kit (Stratagene, La
Jolla, CA) and the mutagenic primer (5′-CCGACCGGGACAAGTTAGT-
CATCTTCCTCG-3′). The F71L mutation was conﬁrmed by automated
DNA sequencing. Expression plasmids were introduced into Escheri-
chia coli strain BL21 and cultured as previously described for
overexpression of recombinant proteins [16,17].
2.9. Puriﬁcation of the wild-type and mutant recombinant αA-crystallin
The recombinant wild-type and F71L αA-crystallins were over-
expressed in E. coli using IPTG, the proteins were puriﬁed to
homogeneity essentially according to previously reported methods
[17]. The homogeneity of puriﬁed F71L and wild-type αA-crystallin
was assessed by SDS-PAGE and simultaneously with immunodetec-
tion using polyclonal anti-αA-crystallin antibodies [18]. The concen-
trations of wild-type and mutant proteins were estimated by Lowry
method.
2.10. Size exclusion chromatography
The molecular size of the wild-type and mutant proteins was
determined by the gel ﬁltration chromatography on a 600×7.5 mm
TSK-G4000 SW column (Tosoh Co., Japan) using a Shimadzu HPLC
system [19]. The column was equilibrated with 0.1 M sodium
phosphate buffer, pH 6.9, containing 0.1 M sodium sulfate at a ﬂow
rate of 1 ml/min. Column was calibrated using standard molecular
weight markers (thyroglobulin—669, γ-globulin—160, BSA—67, oval-
bumin—45 kDa).Table 1
Baseline characteristic features found in different types of age-related cataract patients and
NC CC PSC
N % N % N
Total 205 28.8 182 25.5 178
Males 93 45.4 86 47.5 75
Females 112 54.6 96 52.7 103
Early onset 22 10.7 48 26.4 55
Late onset 183 89.2 134 73.6 123
Familial 34 16.5 30 16.4 28
Non-familial 171 83.4 152 83.5 150
Consanguineous 36 17.5 31 17.0 39
Non-consanguineous 169 82.4 151 82.9 139
Tobacco 61 29.7 55 30.2 48
Non-tobacco 144 70.2 127 69.8 130
Smokers 51 34.8 47 54.6 40
Non-smokers 42 43.7 39 15.3 35
Alcholics 46 22.4 30 16.5 33
Non-alcoholics 159 77.6 152 83.5 145
Vegetarians 10 4.9 19 10.4 05
Non-vegetarians 195 95.1 163 89.6 173
For smokers data, only male subjects of cases and controls were reported to be smoker
MT—mixed type cataracts.2.11. Tryptophan ﬂuorescence
The intrinsic tryptophan ﬂuorescence spectra of wild-type and
mutant αA-crystallin were analyzed using Jasco-FP-6500 spectro-
ﬂuorometer (JASCO Corporation, Tokyo, Japan). Protein samples of
0.1 mg/ml in 20 mM sodium phosphate buffer pH 7.2 were excited at
280 nm and emission spectrawere recorded between 300 and 400 nm.
2.12. ANS ﬂuorescence
The relative surface hydrophobicity of wild-type and mutant αA-
crystallin was measured using 8-anilino-1-naphthalene sulfonic acid
(ANS). Protein samples of 0.1 mg/ml were added to 50 μM of ANS
solution in 10 mM of sodium phosphate buffer. The samples were
excited at 385 nm and the emission spectra were recorded between
400 and 600 nm using a Jasco-FP-6500 spectroﬂuorometer.
2.13. Circular dichroism (CD) studies
Secondary and tertiary structures of the protein were evaluated by
far- and near-UV CD spectra in a Jasco-810 spectropolarimeter (JASCO
Corporation, Tokyo, Japan). Protein concentrations used for far- and
near-UV were 0.1 and 0.5 mg/ml, respectively in 0.1 mg/ml in 20 mM
sodium phosphate buffer, pH 7.2. All the CD spectrawere an average of
six accumulations and corrected with respected blanks.
2.14. Chaperone assays
Chaperone-like activity (CLA) of wild-type and F71L mutant αA-
crystallin was assessed by measuring the ability of these proteins to
suppress the aggregation of different client proteins under different
assay conditions. Heat-induced aggregation of βL-crystallin, γ-crystal-
lin, carbonic anhydrase (CA), and the DTT-induced aggregation of
insulin and lysozymeweremonitored bymeasuring light scattering as
a function of time at 360 nm using a Lamda-35 spectrophotometer
(Perkin-Elmer) essentially according to the previously described
methods [17,20,21].
3. Results
The baseline characteristic features of 711 cases studied showed a
higher incidence in female as compared to males in almost all types of
ARC (Table 1). The mean ages at onset of cataracts were 60.1±9.69 incontrol subjects studied.
MT Total cases Controls
% N % N % N %
25.0 146 20.5 711 – 265 –
42.1 61 42.0 315 44.3 163 61.8
57.9 85 58.0 396 55.7 102 38.5
30.9 33 23.0 158 22.2 – –
69.1 113 77.0 553 77.8 – –
15.7 04 03.0 96 13.5 18 6.7
84.3 142 97.0 615 86.5 247 93.2
21.9 16 11.0 122 17.2 28 10.6
78.1 130 89.0 589 82.8 237 89.4
26.9 48 33.0 212 29.8 – –
73.0 98 67.0 499 70.2 – –
53.3 26 43.0 164 52.1 67 41.1
46.7 35 57.0 151 47.9 96 58.9
18.5 36 25.0 145 20.4 89 33.6
81.5 110 75.0 566 79.6 176 66.4
2.8 11 08.0 45 6.3 37 14.0
97.2 135 92.0 666 93.7 228 86.0
s; NC—nuclear cataracts, CC—cortical cataracts, PSC—posterior subcapsular cataracts,
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subcapsular (PSC) and 58.0±9.91 in mixed type (MT) cataract
patients. The incidence of early onset cases of ARC (age-at-onset
≤50 years) was high in PSC (31%) and CC (26%) as compared to NC
(11%). The low frequency of NC cases among early onset of ARC is
expected as the mean age at expression for the condition in the
present study was 60.1±9.69. Table 1 also provides further informa-
tion such as the frequency of smoking, alcohol consumption, family
history and consanguinity of control subjects and cataract patients.
A mobility shift was observed following SSCP analysis of exon-2 of
the CRYAA gene in 3 female patients (2 with nuclear and 1 with
mixed type cataract) out of 711 subjects diagnosed with ARC. Such
change was not observed among 265 age-matched controls (Fig. 1A).
The mobility shift indicated that the mutation could be homozygous.
Direct sequencing of ampliﬁed products from these patients iden-
tiﬁed a novel single base alteration of C N A transversion at position
213 (counting the A of the start codon as no. 1) in exon-2 of CRYAA
gene. This change predicts a substitution of leucine (TTA; L) for
phenylalanine (TTC; F) at amino acid position 71 (F71L) (Fig. 1B). The
chromatogram conﬁrmed the mutation was homozygous for the
transversion C N A. The age-at-onset of cataract in these patients
ranged between 48 and 50 years and hence was considered as earlyFig. 1. Screening of mutations in CRYAA exon-2 in normal subjects and ARC patients. Panel A: S
an arrow). Lanes with mobility shift (shown with arrows) represent the samples from two
denaturing PAGE gels. Rest of the lanes (without mobility shift) represents samples of non-
Panel B: Sequence analysis of a partial fragment of exon-2 of the CRYAA gene. Arrows indicate
(TTC) to leucine (TTA) at amino acid position 71 (F71L). Panel C: RFLP analysis of PCR produc
generating fragments of 75, 60 and 22 bp for wild-type (without mobility shift) and fragmonset of ARC in view of the mean age of NC cases (60 years) found in
the present study. This genetic change was further conﬁrmed by RFLP
analysis by designing primers with mismatch. Restriction fragment
length polymorphism analysis of ARC patients was done using Dpn II
restriction enzyme that recognizes 5′↓GATC site. The analysis showed
three fragments of 75, 60 and 22 bp for wild-type and two fragments
of 97 and 60 bp for mutant forms as expected (Fig. 1C). This con-
ﬁrmed the homozygosity of the mutation F71L in all the 3 patients.
All the 3 patients with the mutations were unrelated and did not
report any family history of congenital or senile cataracts at the time
of investigation.
We then cloned bothwild-type andmutant genes and expressed in
E. coli to understand the effect of F71L conversion on structural and
the chaperone properties. Fig. 2A shows the SDS-PAGE proﬁle of wild-
type and mutant proteins before and after induction as well as
homogeneity of puriﬁed recombinant αA-crystallins. Polyclonal anti-
αA-crystallin antibodies [18] were able to recognize the F71L-αA-
crystallin (Fig. 2B). Size exclusion chromatography analysis revealed
similar elution time both for the mutant and wild-type proteins
suggesting insigniﬁcant differences in the molecular masses of their
oligomeric complexes (Fig. 3). Dynamic light scattering (DLS) data
also suggest insigniﬁcant change in hydrodynamic volume of theSCP gel showing the mobility shift pattern in the 3 patient samples of ARC (indicated by
nuclear cataract and one mixed type cataract patients with F71L mutation on 12% non-
cataractous healthy control subjects and samples from ARC patients without mutation.
substitution of C N A at position 213 which resulted in the substitution of phenylalanine
ts of exon-2 of the CRYAA gene upon restriction digestionwith Dpn II restriction enzyme
ents of 97 and 60 bp for mutant form (mobility shift shown with arrows).
Fig. 2. Panel A: SDS-PAGE proﬁle of wild-type and F71L-αA-crystallin at various stages
of expression and puriﬁcation. Lanes 1 and 2 represent before and after induction of
wild-type, lanes 3 and 4 represent before and after induction of F71L αA-crystallin,
lanes 5 and 6 represent puriﬁedwild-type and F71LαA-crystallin and laneM represents
molecular weight marker. Panel B: Immunoblot analysis of fractions of F71L-αA-
crystallin obtained from ﬁnal gel ﬁltration step using polyclonal αA-crystallin speciﬁc
antibody.
Fig. 4. Far- (Panel A) and near-UVCD spectra (Panel B) ofwild-type and F71L-αA-crystallin.
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UV CD spectra (Fig. 4) of αAF71L mutant proteinwere similar to wild-
type αA-crystallin suggesting no major difference in their secondary
and tertiary structures, respectively.
Intrinsic tryptophan ﬂuorescence of the proteins showed that the
emission maxima for both proteins were similar, indicating no change
in the tryptophan environment of the F71L mutant protein when
compared to wild-type protein (Fig. 5A). Further, tryptophan
ﬂuorescence data corroborate near-UV CD spectra supporting the
ﬁndings that F71L mutation is unlikely to affect the tertiary structure.
As it is understood, ANS is a hydrophobic site-responsive probe, which
has negligible ﬂuorescence in aqueous media. Binding of this probe to
hydrophobic sites in proteins results in a several fold enhancement in
its ﬂorescence with a shift in the emission maximum to a lower
wavelength. The ANS ﬂuorescence emission spectra of both the
mutant and wild-type protein were similar suggesting unaltered
surface hydrophobicity due to this mutation (Fig. 5B).
In heat-induced aggregation of βL-crystallin, the F71L mutant
showed about 50% less CLA as compared to wild-type αA-crystallin
(Fig. 6). Similarly, the CLA of F71L mutant was decreased by
approximately 35% in heat-induced aggregation of γ-crystallin when
compared to wild-type of αA-crystallin (Fig. 7A). F71L mutant
displayed almost no CLA (90% loss) in heat-induced aggregation of
CA as compared to wild-type αA-crystallin (Fig. 7B). Although, CLA
measurements were routinely carried out at high temperature (60 °C),
the physiological relevance of these assays is in question as the humanFig. 3. Size exclusion chromatography proﬁle of wild-type and F71L-αA-crystallin on a
TSK G-4000 SW size exclusion column. Position of molecular weight markers is shown
on top, (a) thyroglobulin—669, (b) γ-globulin—160, (c) BSA—67 and (d) ovalbumin—
45 kDa.lenses seldom expose to that high temperature. Therefore, we have
measured CLA of native and mutant αA-crystallins at physiological
temperatures. Similar to heat assays, in DTT-induced aggregation of
lysozyme assay, the F71L mutant showed about 50% less CLA as
compared to wild-type αA-crystallin (Fig. 8B). However, decrease in
the CLA of F71L mutant was marginal (10–15% loss) in DTT-induced
aggregation of insulin when compared to wild-type of αA-crystallin
(Fig. 8A).
4. Discussion
In this study, we identiﬁed a novel mutation in the exon-2 of
CRYAA gene in three unrelated female sporadic cases among 711 ARC
patients and characterized the functional signiﬁcance of this missense
mutation. The data revealed that despite insigniﬁcant structural
changes, the F71L mutant αA-crystallin displayed signiﬁcant loss of
CLA in thermal and chemical aggregation assays.
Previous epidemiological studies have established that cataract
development is affected by various factors such as diabetes, female
gender, sunlight or UV light exposure, myopia, nutritional deﬁcien-
cies, trauma and steroid use [1,2,22,23]. Although, epidemiological
studies reported the involvement of genetic factors in the pathogen-
esis of age-related cataracts [3–11], the roles of speciﬁc genes
causing susceptibility to the condition are not established and only a
beginning is made with focus on unraveling underlying genetic basis
and genome wide scanning for ARC. However, there are now several
reported mutations in congenital and hereditary cataracts involving
genes that encode proteins with structural, metabolic, transport
functions [24–26]. It is plausible that some of these genes may be
involved in adult cataract with late expression of phenotype due to
interaction with several noxious factors along with aging process.
Fig. 5. Tryptophan (Panel A) and ANS ﬂuorescence spectra (Panel B) of wild-type and
F71L-αA-crystallin.
Fig. 6. Chaperone-like activity of wild-type and F71L-αA-crystallin in heat-induced
aggregation of βL-crystallin assay. Panel A: Representative graph of chaperone activity
of αA-crystallin in suppressing heat-induced aggregation of βL-crystallin at 60 °C.
Solid curve—0.25 mg/ml of βL-crystallin; dashed curve—0.25 mg/ml of βL-crystallin
with 0.05 mg/ml of wild-type αA-crystallin and dotted curve, 0.25 mg/ml of β-
crystallin with 0.05 mg/ml of F71L-αA-crystallin. Panel B: Relative chaperone activity
(percentage protection) of wild-type and F71L-αA-crystallin in βL-crystallin assay.
Percentage protection was determined considering aggregation of βL-crystallin in the
absence of α-crystallins as 100%. Data are mean±SD (n=4).
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for up to 90% of total soluble protein [12,13,27]. There are three distinct
families of crystallins: α-, β- and γ-crystallins, whose structure,
stability and short-range interactions are thought to contribute to the
lens transparency [12,13,27]. The human lens is also susceptible to
age-related degenerative changes such as accumulation of insoluble
proteins and oxidative damage and hence senile cataract has become
the most common form of blindness [27]. In humans, lenticular α-
crystallin exists as a hetero-oligomer of approximately 800 kDa with
two subunits, αA and αB occurring in a stoichiometry of 3:1
[12,14,20]. αA-Crystallin appears to be largely lens-speciﬁc, whereas
αB-crystallin is also expressed in many other tissues. Both of these
proteins are known for their chaperone activity as evident from sup-
pression of protein aggregation [13,14]. Thus they presumably protect
other lens proteins from the adverse effects of heat, chemicals, and UV
light irradiation. Hence, α-crystallins are instrumental in maintaining
transparency of the lens with their CLA [13,14].
Recently, several mutations in α-crystallins have been associated
with cataract in humans [3,13,14, 24–26,28]. But there are no reports
on CRYAA gene mutations in ARC. This is the ﬁrst report of an F71L
mutation in αA-crystallin being associated with ARC in Indian
patients. Nevertheless, the reasons for the time lag shown by this
mutation in the expression of a cataract phenotype around 50 years of
age are not clear. Certain mutations may have delayed expression,
mostly because of interactionwith several triggering factors including
aging, cross-linking of DNA and proteins resulting in the formation of
adducts. Therefore, we have investigated the underlying molecular
basis of F71L mutation in causing cataract by biochemical and
biophysical approaches.
It is observed that this mutation did not lead the gross structural
changes of the protein in terms of apparent molecular mass of oligo-meric complex, the secondary and tertiary structures and the surface
hydrophobicity ofαA-crystallin under native conditions. Interestingly,
the CLA of F71L mutant αA-crystallin varied with different client
proteins under different assay conditions. For example, it showed loss
(15–90%) of CLA in thermal and chemical aggregation assays com-
pared to native recombinant αA-crystallin. A previous study also
reported that Phe71 is essential for CLA of αA-crystallin [29].
Replacement of Phe71 with Gly (F71G) did not result in signiﬁcant
structural changes, but had severely impaired CLA of αA-crystallin
[29]. Likewise, there are many instances where alterations in oligo-
meric size, structure and hydrophobicty are not uniformly associated
with loss or gain of CLA of α-crystallin.
Although, there are no gross structural changes, αA-crystallin
subunits encoded by the F71L mutant allele might be affected by
minor but subtle alterations and may be less stable than wild-type
subunits. Given that lens polypeptides normally have an extremely
long half-life in lens ﬁber cells, it seems reasonable that loss of
stability associated with the F71L mutation could result in a pre-
mature loss of overall CLA in the lens. Indeed we observed an
increased light scattering by the mutant protein at 85 °C as compared
to wild-type αA-crystallin (Fig. 9). Further, during DLS studies F71L
mutant was found to precipitate on preheating (heating for 15 min at
60 °C and cooled back to room temperature) where as wild-type
Fig. 8. Panel A: Relative chaperone activity of wild-type and F71L-αA-crystallin in DTT-
induced aggregation of insulin assay. Percentage protection was determined consider-
ing DTT-induced aggregation of insulin (0.4 mg/ml) in the absence of α-crystallins at
60 °C as 100%. Concentration of wild-type and F71L αA-crystallin was 0.25 mg/ml.
Data are mean±SD (n=4). Panel B: Relative chaperone activity of wild-type and
F71L-αA-crystallin in DTT-induced aggregation of lysozyme assay. Percentage protec-
tion was determined considering aggregation of lysozyme (0.5 mg/ml) in the absence
of α-crystallins as 100%. Concentration of wild-type and F71L αA-crystallin was
0.5 mg/ml. Data are mean±SD (n=4).
Fig. 7. Panel A: Relative chaperone activity of wild-type and F71L-αA-crystallin in heat-
induced aggregation γ-crystallin assay. Percentage protection was determined
considering aggregation of γ-crystallin (0.2 mg/ml) in the absence of α-crystallins as
100%. Concentration of wild-type and F71L αA-crystallin was 0.025 mg/ml. Data are
mean±SD (n=4). Panel B: Relative chaperone activity of wild-type and F71L-αA-
crystallin in heat-induced aggregation carbonic anhydrase (CA) assay. Percentage
protectionwas determined considering heat-induced aggregation of CA (0.2 mg/ml) in
the absence of α-crystallins at 60 °C as 100%. Concentration of wild-type and F71L αA-
crystallin was 0.2 mg/ml. Data are mean ± SD (n=4).
980 S.G. Bhagyalaxmi et al. / Biochimica et Biophysica Acta 1792 (2009) 974–981remained in solution.1 These results reinforce the possibility that this
mutation which can cause subtle structural alterations in association
with other environmental factors, may predispose towards the
cataract phenotype. This may explain the late age onset of cataract
in individuals who are carriers of this mutation. Further, these results
highlight the importance ofαA-crystallin, which is themore abundant
sub unit in the α-crystallin hetero-oligomer. Recently we reported
that α-crystallin oligomers with αA and αB subunits in a 3:1 molar
ratio could be a favored combination for lens to achieve optimal
protection under both native and stress conditions [20]. Further,
despite high sequence homology, αA- and αB-crystallins behave
differently with increasing temperature. For example, at high
temperatures recombinant αA-crystallin shows higher CLA than
recombinantαB due to some structural transitions [17,30]. In addition,
studies from our laboratory2 and elsewhere indicate that αA-protects
αB-crystallin from heat-induced aggregation/precipitation [13,31,32].
There is a good evidence to suggest that αA is more critical for lens
than αB-crystallin. Hence, the preliminary data which indicate an
altered stability for F71L mutant gain attention. Nevertheless, further
investigations are necessary to understand the other possible factors
that might predispose this genetic effect.1 PNBS Srinivas and GB Reddy unpublished data.As reviewed [3], in addition to epidemiological evidence implicat-
ing genetic factors in ARC, a number of inherited cataracts due to
mutations in various genes with post infantile age at onset or
progression of cataract all through the life has been reported. TheseFig. 9. Time-course of light scattering monitored for wild-type and F71L αA-crystallin
(0.30 mg/ml) at 85 °C and pH 7.2.
981S.G. Bhagyalaxmi et al. / Biochimica et Biophysica Acta 1792 (2009) 974–981studies indicate that a mutation in some genes that severely perturb
the protein or affects its function might result in congenital cataracts,
while a mutation that causes less signiﬁcant damage to the same
protein might lead to ARC in a more complex multifactorial fashion.
For example, mutations in heat shock transcription factor 4 were
observed in ARC, which account for only a small fraction of 150
sporadic, age-related cortical cataracts in a Chinese population [33].
Hence, it may be inferred that late expression of mutant allele in
conjuncture with other triggering factors ultimately bringing down
CLA in vivo may lead to the condition (NC).
In summary, we identiﬁed a novel mutation (F71L) in the exon-2 of
CRYAA gene associated ARC. Further, we demonstrated that though
F71L mutation did not cause major structural changes, the F71L
mutant protein has substantially lowered CLA. Thus, as suggested by
Murugesan et al. [34], the age-at-onset of cataract in individuals
carrying this mutation may be due to the overall loss of in vivo
chaperone activity of α-crystallin. However, in addition, there could
be structural alterations due to F71L mutation with time due to
environmental factors. For example, F71L mutant might be more
susceptible to age-related posttranslational modiﬁcations. Since the
patients with F71L αA-crystallin developed cataract during their
elderly life i.e., around 50 years of age, decreased CLA and possibly
along with some age-related modiﬁcations in patients carrying the
mutation might be the possible underlying mechanism.
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